Setting up 'COVID-19 free' hospital areas for surgical patients could save lives during the second wave of the pandemic – reducing the risk of death from lung infections associated with coronavirus.
The process of white blood cells responding to infections begins earlier than previously thought, according to a new study by scientists at the University of Birmingham.
A newly published study led by the Universities of Oxford and Birmingham has found that, compared to other cancers, patients with blood cancers are more vulnerable to the effects of the coronavirus pandemic.
A pioneering lung cancer study has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.
Dr Justin Loke has become one of the first-ever recipients of the American Association for Cancer Research (AACR) – Cancer Research UK (CRUK) Transatlantic Fellowships.
Amanda Solloway MP, the Minister for Science, Research and Innovation recently visited the University of Birmingham to mark the launch of the Government's R&D roadmap.
Professors David Wraith and Peter Cockerill write for The Conversation on their research that has shown that you can stop the immune system attacking the nerves.
Two UK drugs companies will be the first to partner with the Universities of Birmingham and Oxford as part of a major new UK drugs trial to test potential therapeutics to treat patients hospitalised with COVID-19.
The body's immune system can be re-wired to prevent it from recognising its own proteins which, when attacked by the body, can cause autoimmune diseases like multiple sclerosis.
Heightened caution is needed when considering de-escalation trials for patients with Human papillomavirus (HPV)-positive oropharyngeal cancer (OPC), to ensure minimal harm to patients.